News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Fervo Energy raised $1.89 billion in an upsized IPO, valuing the company near $7.66 billion ahead of its Nasdaq listing.
  • U.S. futures slipped after equities fell on a stronger-than-expected April CPI print, boosting concerns about Fed rate persistence.
  • President Trump said preventing Iran obtaining a nuclear weapon outweighs U.S. economic pain, signaling higher risk of prolonged conflict.
  • U.S. Treasury envoy met China’s vice premier in South Korea to discuss trade, U.S. goods purchases and semiconductor export curbs ahead of the Beijing summit.
  • Oil prices paused after a three-day rally, leaving Brent and WTI elevated amid ongoing supply risks around the Strait of Hormuz.
  • Samsung said pay talks broke down and warned of a potential 18‑day strike that could disrupt AI and chip production.
  • Vietnam’s state oil trader asked U.S. authorities to allow a redirected supertanker to proceed, citing urgent refinery supply needs.

Latest Articles

EchoStar Sees Sharper Subscriber Decline as Cord-Cutting Continues

EchoStar Sees Sharper Subscriber Decline as Cord-Cutting Continues

EchoStar reported a steeper-than-expected drop in pay-TV subscribers in the first quarter, reflecting continued consumer migration from bundled television to streaming. While pay-TV revenue and consolidated sales modestly exceeded analyst estimates and the quarterly loss narrowed year-over-year, the company remains engaged in debt restructuring tie…

Norwegian Cruise Line Director Executes Substantial Common Stock Purchase

Norwegian Cruise Line Director Executes Substantial Common Stock Purchase

A significant insider transaction has been recorded for Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH). Zillah Byng-Thorne, a member of the company's board of directors, has increased her position in the firm through the acquisition of common stock valued at $521,394. These transactions, as disclosed in a recent Form 4 filing with the Securities a…

Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026

Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026

Cellectar Biosciences, a clinical-stage biopharmaceutical company specializing in cancer treatments, announced it will report its Q1 2026 financial results and provide a corporate update on May 14, 2026. The company is developing multiple proprietary cancer drug candidates, including iopofosine I 131, CLR 121125, and CLR 121225, which are in variou…

Sharplink Reports First Quarter 2026 Financial and Operating Results; Now Holds 872,984 ETH in Treasury

Sharplink Reports First Quarter 2026 Financial and Operating Results; Now Holds 872,984 ETH in Treasury

Sharplink, Inc. reported Q1 2026 financial and operating results with a material increase in total revenue driven by its actively managed Ethereum treasury strategy. The company holds approximately 872,984 ETH, reflecting growth in its ETH concentration metric and total staking rewards of 18,800 ETH since June 2025. Sharplink announced plans for th…

Sinclair Inc. To Appear at Upcoming Investor Conferences

Sinclair Inc. To Appear at Upcoming Investor Conferences

Sinclair, Inc., a diversified media company, announced its participation in two key investor conferences in May 2026: Barclays 30th Annual Leveraged Finance Conference and J.P. Morgan Global Technology, Media and Communications Conference. The company will offer a live webcast of its fireside chat at the J.P. Morgan event, featuring top executives,…

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Apyx Medical Corporation announced that it received expanded FDA 510(k) clearance for its AYON Body Contouring System to include power liposuction, an advanced liposuction technique that enhances fat removal efficiency and reduces surgeon effort and operating room time. The company plans a limited commercial launch to refine utilization prior to br…

TRIO PETROLEUM CORP ANNOUNCES STRATEGIC EXPANSION INITIATIVE FOLLOWING SUCCESSFUL CAPITAL RAISE AND ENCOURAGES STOCKHOLDER SUPPORT AT MAY 21ST ANNUAL MEETING

TRIO PETROLEUM CORP ANNOUNCES STRATEGIC EXPANSION INITIATIVE FOLLOWING SUCCESSFUL CAPITAL RAISE AND ENCOURAGES STOCKHOLDER SUPPORT AT MAY 21ST ANNUAL MEETING

Trio Petroleum Corp has raised approximately $24 million through its ATM equity program, strengthening its balance sheet to pursue growth via strategic acquisitions, especially in the Canadian oil and gas sector. The company assembled a multidisciplinary team to identify and execute acquisition opportunities, aiming to expand production, reserves, …

Gray Announces Participation in Upcoming Investor Events

Gray Announces Participation in Upcoming Investor Events

Gray Media, Inc., a leading multimedia company owning a large portfolio of local TV stations and digital assets, will participate in several upcoming major investor events between May and June 2026, including the Needham Technology, Media & Consumer Conference, Goldman Sachs Leveraged Finance Conference, and Gabelli Sports & Media Symposium. The co…

Standard Lithium Reports First Quarter 2026 Results

Standard Lithium Reports First Quarter 2026 Results

Standard Lithium Ltd. reported its Q1 2026 results, signing its first binding lithium carbonate offtake agreement with Trafigura, achieving key operational milestones in its Arkansas Demonstration Plant, and progressing toward a Final Investment Decision and construction start in 2026 for the South West Arkansas Project. The company continues to ex…

Lincoln Educational Services Reports Strong First Quarter Financial Results, Raises Guidance for Full-Year 2026

Lincoln Educational Services Reports Strong First Quarter Financial Results, Raises Guidance for Full-Year 2026

Lincoln Educational Services Corporation reported strong first quarter 2026 financial and operational results, including a 22.5% revenue increase to $144 million and net income more than doubling to $4.4 million. Student starts grew 19.5%, exceeding expectations. The company raised its full-year 2026 guidance for revenue, adjusted EBITDA, net incom…

Exagen Inc. Reports First Quarter 2026 Results

Exagen Inc. Reports First Quarter 2026 Results

Exagen Inc., a leading provider of autoimmune diagnostics, announced its financial results for Q1 2026, recording a 12% increase in revenue to $17.3 million compared to Q1 2025. The company grew its AVISE CTD test volume by 10% and increased its average selling price per test by 6%. Although still operating at a loss, Exagen improved its adjusted E…

Uniti Group Inc. Reports First Quarter 2026 Results

Uniti Group Inc. Reports First Quarter 2026 Results

Uniti Group Inc. announced its Q1 2026 financial results, reporting consolidated revenue of $987.5 million and an adjusted EBITDA of $441.6 million, marking year-over-year growth as a combined company following its merger with Windstream. The company achieved its highest consumer fiber net adds on record and continues progressing towards its goal t…

Galectin Therapeutics Announces Publication of NAVIGATE Phase 2b Trial Results for Belapectin in the Journal of Hepatology

Galectin Therapeutics Announces Publication of NAVIGATE Phase 2b Trial Results for Belapectin in the Journal of Hepatology

Galectin Therapeutics announced the publication of Phase 2b NAVIGATE trial results evaluating belapectin, a galectin-3 inhibitor, in MASH cirrhosis patients with portal hypertension. The trial demonstrated a numerical and statistically significant reduction in new esophageal varices and supportive biomarker improvements, with favorable safety. Thes…